US-based healthcare technology company Claritas Rx has launched Patient Watchtower, the first coordination platform specifically designed for speciality and rare disease patients.
The advanced software-as-a-service (SaaS) solution integrates complex and fragmented patient data from multiple sources, delivering immediate actionable insights.
It leverages artificial intelligence and machine learning (AIML) technologies to enable precise microtargeting of patients based on their risk factors, ensuring timely treatment.
The platform manages the health enablement and access team (HEAT) for each patient, including case managers, speciality pharmacies, field teams, hubs, and patient support call centres.
The coordination allows biopharma companies to use real-world, first-party data from care coordination organisations for initiating patient support and interventions.
Claritas Rx CEO Mike Fitzgibbons said: “Hyper-targeted coordination of disparate groups within a health enablement and access team (HEAT) allows biopharma companies to potentially increase their fill rate by 20%.
“For many speciality brands, this type of uplift can mean millions of dollars and more importantly, getting treatment to a patient faster.
“Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”
Patient Watchtower is tailored for patient services teams and offers several key features.
The features include a customised patient journey dashboard that provides an overview of the patient experience as envisioned by the company.
Its daily status updates feature allows Patient Services teams to view high-priority patient cases that require immediate attention.
The platform provides instant access to detailed case histories and facilitates real-time information sharing, promoting collaboration with partners.
Also, predictive analytics powered by machine learning assess patient risk factors, such as prescription discontinuation and abandonment, allowing for proactive intervention strategies.
Patient Watchtower, a part of the Claritas Rx Ascend platform, simplifies data input and setup, streamlining patient risk assessments and intervention planning.
Ascend employs hundreds of predictive factors to provide a comprehensive perspective, enabling Field Access Teams to determine the next best action.
Furthermore, Patient Watchtower transforms raw data into actionable insights, revealing hidden narratives that can explain why a patient may discontinue treatment.
